Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
TAR-200 vs Intravesical Chemotherapy After BGC: Phase 3 Sun-RISe-5 in Non–Muscle-Invasive Bladder Cancer
SunRISe-1: TAR-200 in BCG-Unresponsive High-Risk Bladder Cancer
Real-World Sequencing and Survival in Locally Advanced Prostate Cancer
Making the Case for Dual Ang-2/VEGF-A Inhibition: Anatomical Benefits
Jennifer I. Lim, MD, FARVO
Carl Regillo, MD
ATTRv-PN: A Family Affair?
John Berk, MD
Noel Dasgupta, MD, FACC
ATTR Amyloidosis: Familial Vs Wild-Type
The Multiple Faces of ATTRv-PN
Sami Khella, MD
Marcia Waddington-Cruz, MD, PhD
Heads Up: It Might Be ATTRv Polyneuropathy – A Microlearning Course on Diagnosis and Treatment
ATTRv-PN: A Complicated Disease With a Poor Prognosis
Raising the Red Flag: What's Your Index of Suspicion for ATTRv-PN?
Shh…Gene-Silencing Therapies for ATTRv-PN
GPRC5D-Targeted Bispecifics in Relapsed/Refractory Multiple Myeloma: Practical Expert Consensus on a New Target with Unique Adverse Events
Jeffrey V. Matous, MD
Donna Catamero, NP
Ajai Chari, MD
Don't Flush Another Colonoscopy Down the Toilet
Douglas Rex, MD
Aasma Shaukat, MD, MPH
Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer
Javier Cortes, MD, PhD
Komal Jhaveri, MD, FACP
Phase-3 SunRISe-2: TAR-200 Plus Cetrelimab Versus Chemoradiotherapy in Muscle-Invasive Bladder Cancer
Updates from Apa-RP: Apalutamide and ADT in High-Risk Localized Prostate Cancer
Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
Omer Abdul Hamid, MD
Nancy Kuntz, MD
Migvis Monduy, MD
Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying
Managing Pulmonary and Cardiac Adverse Events Related to ADC Therapy in Breast Cancer
Nadia Harbeck, MD, PhD
Diagnosing ATTRv-PN: What's in Your Toolbox?
Applying SDM to Personalize Treatment Discussions on Recurrence Risk Reduction in Patients with Early-Stage Melanoma
Meghan Mooradian, MD
Quality Indicators: How Do You Compare? Part 1
New and Emerging Agents
David Johnson, MD
Inadequate Bowel Prep: The Achilles' Heel of Colorectal Cancer Screening Colonoscopy
Another Inadequate Bowel Prep? It May Not Be the Patient's Fault
Loading...
We’re glad to see you’re enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.